Phase I clinical study of a personalized peptide vaccination for patients infected with hepatitis C virus (HCV) 1b who failed to respond to interferon-based therapy
- Resource Type
- Article
- Source
- In
Vaccine 2007 25(42):7429-7435 - Subject
- Language
- ISSN
- 0264-410X